Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.01%

Published 2019-12-03, 05:25 p/m
Updated 2019-12-03, 05:25 p/m
© Reuters.  U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.01%

Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Oil & Gas, Basic Materials and Consumer Services sectors propelled shares lower.

At the close in NYSE, the Dow Jones Industrial Average lost 1.01%, while the S&P 500 index declined 0.66%, and the NASDAQ Composite index lost 0.55%.

The biggest gainers of the session on the Dow Jones Industrial Average were Merck & Company Inc (NYSE:MRK), which rose 0.39% or 0.34 points to trade at 87.38 at the close. Verizon Communications Inc (NYSE:VZ) added 0.30% or 0.18 points to end at 60.14 and Procter & Gamble Company (NYSE:PG) was up 0.19% or 0.23 points to 122.95 in late trade.

Biggest losers included Intel Corporation (NASDAQ:INTC), which lost 2.76% or 1.59 points to trade at 56.07 in late trade. Dow Inc (NYSE:DOW) declined 2.52% or 1.34 points to end at 51.82 and Goldman Sachs Group Inc (NYSE:GS) shed 2.48% or 5.40 points to 212.24.

The top performers on the S&P 500 were Crown Castle International Corp (NYSE:CCI) which rose 2.44% to 134.15, DXC Technology Co (NYSE:DXC) which was up 2.33% to settle at 36.90 and Take-Two Interactive Software Inc (NASDAQ:TTWO) which gained 1.97% to close at 123.11.

The worst performers were Apache Corporation (NYSE:APA) which was down 5.94% to 18.38 in late trade, Unum Group (NYSE:UNM) which lost 5.05% to settle at 28.94 and Cimarex Energy Co (NYSE:XEC) which was down 4.72% to 45.41 at the close.

The top performers on the NASDAQ Composite were Audentes Therapeutics Inc (NASDAQ:BOLD) which rose 105.98% to 58.93, OUTLOOK THERAPEUTICS INC (NASDAQ:OTLK) which was up 53.12% to settle at 1.59 and Motif Bio PLC (NASDAQ:MTFB) which gained 50.05% to close at 0.14.

The worst performers were Aslan Pharmaceuticals Ltd ADR (NASDAQ:ASLN) which was down 49.62% to 2.62 in late trade, Protagonist Therapeutics Inc (NASDAQ:PTGX) which lost 47.01% to settle at 4.69 and Cara Therapeutic (NASDAQ:CARA) which was down 34.56% to 16.93 at the close.

Declining stocks outnumbered rising ones by 1742 to 1094 and 97 ended unchanged; on the Nasdaq Stock Exchange, 1641 fell and 996 advanced, while 81 ended unchanged on the New York Stock Exchange.

The CBOE Volatility Index, which measures the implied volatility of S&P 500 options, was up 7.04% to 15.96 a new 1-month high.

In commodities trading, Gold Futures for February delivery was up 0.97% or 14.25 to $1483.45 a troy ounce. Meanwhile, Crude oil for delivery in January rose 0.61% or 0.34 to hit $56.30 a barrel, while the February Brent oil contract rose 0.11% or 0.07 to trade at $61.15 a barrel.

EUR/USD was up 0.00% to 1.1081, while USD/JPY rose 0.02% to 108.64.

The US Dollar Index Futures was down 0.12% at 97.678.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.